NVAX Jul 2024 3.500 call
| Previous Close | 1.25 |
| Open | 6.40 |
| Bid | 5.35 |
| Ask | 5.50 |
| Strike | 3.50 |
| Expire Date | 2024-07-19 |
| Day's Range | 6.40 - 7.23 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 93 |
- Yahoo Finance Video
Fed rates, Tesla Supercharger backpedal, Novavax's 'new chapter': Market Domination
On today's episode of Market Domination, Yahoo Finance Hosts Julie Hyman and Josh Lipton break down the latest earnings and major trends Wall Street analysts are eyeing. Sweetgreen (SG) shares soar after the company topped first quarter revenue estimates and raised full-year guidance. Similarly, Taiwan Semiconductor Manufacturing Company (TSM) shares are rising after the company reported that its sales jumped nearly 60% year over year, largely due to AI demand. Morgan Stanley Wealth Management Managing Director Dan Skelly joins Market Domination to discuss some signs pointing to the Fed potentially cutting interest rates several times before the end of the year. Novavax (NVAX) shares skyrocket after the company announced a $1.2 billion vaccine deal with French drugmaker Sanofi (SNY). B. Riley Securities Managing Director & Group Head of Healthcare Research Mayank Mamtani explains how the partnership marks a "new chapter" for Novavax after a post-pandemic slump. Yahoo Finance reporter Pras Subramanian joins to discuss Tesla (TSLA) CEO Elon Musk backpedaling his recent move to shrink the company's Supercharger team. As many legacy automakers signed up to participate in Tesla's Supercharger network, Subramanian says Musk is trying to fix the issue he created after laying off a majority of the Supercharger team. A new edition of Good Buy or Goodbye analyzes two companies in the finance sector: PayPal (PYPL) and Goldman Sachs (GS). This post was written by Melanie Riehl
Barrons.comAlight, Novavax, and More Stocks See Action From Activist Investors
Starboard Value reached a cooperation agreement with Alight, a provider of cloud-based human capital and technology services. Shah Capital launched a proxy campaign at biotech Novavax.
BloombergNovavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the stock to exit their positions at a loss. Most Read from BloombergApple Nears Deal With OpenAI to Put ChatGPT on iPhoneIce Cube’s Big3 Basketball League Sells Its First Team in $10 Million DealFord Cuts Battery Orders as EV Losses Top $100,000 Per CarElon Musk Pledges to Grow Supercharger Business He Just DecimatedJim Simons, Code Breaker Who Mastered Investing, Dies at 86Shares of the vaccine make
